Your session is about to expire
← Back to Search
Radiation Therapy
MR-Guided Radiation Therapy for Cancer (MRgRT Trial)
N/A
Recruiting
Led By Michael Milosevic, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
MRgRT Trial Summary
This trial is testing a new type of cancer treatment that uses magnetic resonance to guide the radiation. They want to see if it works well and if it affects the workflow of the people administering the treatment.
Who is the study for?
This trial is for adults over 18 who can give informed consent and are scheduled to receive imaging or treatment at the Princess Margaret Cancer Centre's MRgRT facility. There are no specific exclusion criteria mentioned.Check my eligibility
What is being tested?
The study focuses on assessing how well magnetic resonance-guided radiation therapy (MRgRT) works in a research setting and its effects on the clinical team's workflow at the cancer center.See study design
What are the potential side effects?
Since this trial is evaluating technical performance rather than a drug, it doesn't list specific side effects like medication trials do. However, general risks may include those typically associated with radiation therapy.
MRgRT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of planned patients receiving treatment in the MRgRT facility
Secondary outcome measures
Measure tumor size before, during and after radiotherapy
MRgRT Trial Design
1Treatment groups
Experimental Treatment
Group I: Magnetic resonance - guided radiation therapy (MRgRT)Experimental Treatment1 Intervention
Magnetic resonance (MR) - guided radiation therapy
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,474 Previous Clinical Trials
484,892 Total Patients Enrolled
Michael Milosevic, MDPrincipal InvestigatorUniversity Health Network, Toronto
10 Previous Clinical Trials
998 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- There are no specific criteria for exclusion or inclusion in this study.
Research Study Groups:
This trial has the following groups:- Group 1: Magnetic resonance - guided radiation therapy (MRgRT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the aggregate number of participants enrolled in this clinical experiment?
"Yes, according to clinicaltrials.gov the trial remains open for recruitment. It was first posted on February 1st 2016 and updated lastly on October 6th 2022; they are currently looking for 150 participants from a single location."
Answered by AI
Are there current opportunities for individuals to enroll in this experiment?
"Clinicaltrials.gov confirms that this study is actively enrolling patients. It was first posted on February 1st 2016 and the information has been modified as recently as October 6th 2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger